Camp4 Therapeutics Corp SEC filings CAMP
Camp4 Therapeutics Corp has 192 filings in SEC EDGAR's recent list, going back to Sep 25, 2018. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 12, 2026 | — |
| SEC STAFF LETTER | Filing | Oct 16, 2024 | — |
| EFFECT | Filing | Oct 10, 2024 | — |
| CERT | Filing | Oct 10, 2024 | — |
| 8-A12B | Form 8-a12b | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Oct 2, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2024 | — |
| DRSLTR | Filing | Aug 22, 2024 | — |
| DRS/A | Filing | Aug 22, 2024 | — |
| SEC STAFF LETTER | Filing | Aug 15, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2024 | — |
| DRS/A | Filing | Aug 2, 2024 | — |
| DRSLTR | Filing | Jul 26, 2024 | — |
| DRS/A | Filing | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| DRS | Filing | Jun 14, 2024 | — |
| D | Filing | Jun 21, 2022 | — |
| D/A | Filing | Oct 29, 2021 | — |
| D | Filing | Mar 19, 2021 | — |
| D | Filing | Sep 25, 2018 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1736730
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.